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Abstract
Carbapenems, “last resort” β-lactam antibiotics, are inactivated by zinc-dependent metallo-β-
lactamases (MBLs). The host innate immune response withholds nutrient metal ions from 
microbial pathogens by releasing metal-chelating proteins such as calprotectin. We show that 
metal sequestration is detrimental for the accumulation of MBLs in the bacterial periplasm, since 
these enzymes are readily degraded in their non-metallated form. However, the New Delhi 
Metallo-β-lactamase (NDM-1) is able to persist under conditions of metal depletion. NDM-1 is a 
lipidated protein anchored to the outer membrane of Gram-negative bacteria. Membrane-
anchoring contributes to the unusual stability of NDM-1 and favors secretion of this enzyme in 
outer membrane vesicles (OMVs). OMVs containing NDM-1 can protect nearby populations of 
bacteria from otherwise lethal antibiotic levels, and OMVs from clinical pathogens expressing 
NDM-1 can carry this MBL and the blaNDM gene. We show that protein export into OMVs can be 
targeted, providing possibilities of new antibacterial therapeutic strategies.
Antibiotic resistance is one of the most serious public health threats plaguing our world1,2. 
This unwelcome clinical development is rapidly accelerating as the result of the global 
spread of antibiotic resistance genes. Carbapenems are “last resort” β-lactam antibiotics 
employed to combat multi-drug resistant bacteria. However, their therapeutic efficacy is 
challenged by the dissemination of genes encoding enzymes able to inactivate carbapenems 
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(i.e., carbapenemases) among Gram-negative Enterobacteriaceae3. There are two types of 
carbapenemases, serine-β-lactamases (SBLs) and metallo-β-lactamases (MBLs). SBLs 
employ an active site serine residue for substrate hydrolysis, whereas MBLs require the 
binding of Zn(II) cofactors for activity4. MBLs are the most difficult to overcome; in 
contrast to SBLs, clinical inhibitors have not yet been developed for these Zn(II)-dependent 
carbapenemases.
MBLs are periplasmic enzymes, and worldwide spread of these resistance factors is 
accelerated by horizontal gene transfer4,5. Among MBLs, the New Delhi Metallo-β-
lactamase (NDM-1) has manifested the fastest and largest geographical spread, involving 
now more than 70 countries6. The blaNDM gene was detected not only in patient samples, 
but also in 30% of surface waters and seepage in New Delhi7, in >60% of environmental 
waters in Bangladesh, and in hospital sewage8 and wastewater treatment plants in China9. 
This scenario reveals an unprecedented environmental dissemination of resistance 
determinants in regions covering half of the human population. Surprisingly, this 
dissemination is not related to the spread of specific clones, specific plasmids, or a single 
genetic structure10.
Clinically relevant MBLs employ two Zn(II) ions as cofactors, which are essential for 
binding and hydrolyzing β-lactam antibiotics4,11. In Gram-negative bacteria, MBLs are 
exported through the SecA/SecYEG system to the periplasm, where they fold and bind the 
Zn(II) ions12. Periplasmic Zn(II) levels are not regulated in most bacteria, thus depending on 
the Zn(II) availability in the extracellular environment13. This situation becomes critical 
during infection, since an innate immune response is elicited which involves sequestration of 
metal ions to starve bacteria of these essential nutrients14. Calprotectin (CP) is an abundant 
metal-chelating protein released at sites of infection by neutrophils. CP binds Zn(II) with 
high affinity and thereby prevents microbial acquisition of this essential nutrient15,16. 
Therefore, to overcome this metal-withholding response, MBLs must withstand conditions 
of limited Zn(II) availability in the host. Recent studies have shown that the active sites of 
MBLs are exquisitely tuned to optimize Zn(II) binding in the periplasm11,17.
Here we demonstrate that metal deprivation not only hampers MBL activity, but also affects 
protein stability. Apo MBLs (devoid of metal ions) formed under zinc-limiting conditions 
are readily degraded in the periplasm, implying that Zn(II) is essential for protein folding in 
the periplasm. In contrast, NDM-1 resists degradation under Zn(II)-limiting conditions. We 
show that the unusual stability of NDM-1 is a result of the protein being lipidated and 
anchored to the outer membrane of Gram-negative bacteria. Membrane-anchoring also 
enables secretion of NDM-1 in outer membrane vesicles (OMVs). These membrane-
enclosed “bacterial packs”, shed by all Gram-negative bacteria, have been associated with 
cellular communication and bacterial pathogenesis18. We show that OMVs containing 
NDM-1 display carbapenemase activity and can protect nearby populations of carbapenem-
susceptible bacteria. We report that OMVs from clinical pathogens expressing NDM-1 can 
carry the protein and the blaNDM gene. Lastly, we also reveal that targeting protein lipidation 
can prevent protein export to vesicles, providing a basis for possible therapeutic approaches.
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 Results
 Zn(II) starvation reduces periplasmic levels of MBLs
Zn(II) limitation in the extracellular medium impairs MBL-mediated resistance by reducing 
the levels of this essential cofactor in the bacterial periplasm19. This phenomenon can be 
elicited by adding metal-chelating agents to the growth medium. In order to compare the 
relative susceptibilities of different MBLs to zinc-limiting conditions, we targeted four 
clinically relevant MBLs (NDM-1, VIM-2, IMP-1 and SPM-1) to the periplasmic space of 
Escherichia coli with their native peptide leaders. The proteins were expressed fused to a C-
terminal Strep-tag to allow for immunodetection and quantitation. Strep-tagging did not 
affect the resistance profile of any of the four MBLs employed (Supplementary Results, 
Supplementary Table 1). We then evaluated the resistance conferred by these MBLs in E. 
coli to two clinically relevant β-lactam antibiotics (cefotaxime and imipenem) upon addition 
of the metal-chelating agent dipicolinic acid (DPA). The minimum inhibitory concentration 
(MIC) values of these antibiotics were highly dependent on Zn(II) availability (Fig. 1a). 
Among the three MBLs prevalent in Enterobacteriaceae (IMP-1, VIM-2, NDM-1), IMP-1 
was more refractory to the addition of DPA compared to NDM-1 or VIM-2, being able to 
confer antibiotic resistance at relatively high concentrations of the chelating agent. 
Resistance by SPM-1 (a MBL intrinsic to Pseudomonas aeruginosa) was reduced only at 
higher concentrations of DPA (Fig. 1a, Supplementary Fig. 1a and Supplementary Table 2). 
In principle, these different susceptibilities could be attributed to distinct metal-binding 
affinities of each MBL; however, Western blot analysis showed that periplasmic 
accumulation of MBLs (i.e., SPM-1, VIM-2, IMP-1) decreased under Zn(II) limitation and 
that these changes varied among the different proteins (Fig. 1b).
VIM-2 could not be detected in periplasmic extracts of cells treated with DPA, correlating 
with the loss of resistance conferred by this enzyme under zinc-deprivation conditions (Fig. 
1a, b). On the other hand, SPM-1 and IMP-1 levels in the periplasm were affected to a lesser 
extent, in agreement with the reduced effect of intermediate concentrations of DPA on the 
resistance conferred by these MBLs. Similar results were obtained when Zn(II) 
sequestration was induced by addition of CP to the medium (Fig. 1b), confirming that the 
phenomenon arises from restricting the external pool of available Zn(II) regardless of the 
chelating agent. NDM-1 was not detected in the periplasmic fraction (Fig. 1b) since this 
enzyme localizes to the bacterial outer membrane20. NDM-1 levels in spheroplasts were 
affected by DPA, but the impact on protein levels was not as drastic as observed for VIM-2 
in the periplasm (Fig. 1b) even though DPA affects the antibiotic resistance profiles of these 
enzymes to comparable degrees (Fig. 1a).
The reduced MBL levels induced by Zn(II) depletion can be attributed to impaired 
expression levels or to protein degradation. To assess the impact of Zn(II) deprivation on 
protein levels during bacterial growth, we treated liquid cultures of E. coli cells expressing 
MBLs with DPA and quantified MBL levels in periplasm, spheroplasts and membrane 
fractions at different time points. Under these conditions, VIM-2 levels rapidly decreased in 
the periplasm. SPM-1 levels, in contrast, were not reduced even after 16 h of incubation 
following DPA addition, and IMP-1 showed an intermediate behavior (Fig. 1c and 
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Supplementary Fig. 1b). This phenomenon of decreased protein levels was exclusive to 
MBLs and, hence, not a result of generalized degradation of periplasmic proteins 
(Supplementary Fig. 5). Moreover, cytoplasmic levels (evaluated from spheroplasts) of MBL 
precursors were unaltered (Supplementary Fig. 1b and 6). We conclude that the impaired 
antibiotic resistance observed upon Zn(II) starvation is a result of MBL degradation in the 
periplasm.
We also determined the amount of NDM-1 sequestered in membrane fractions. In contrast 
with the pattern observed in the antibiotic resistance profile upon addition of DPA, protein 
levels of NDM-1 were moderately reduced (Fig. 1c and Supplementary Fig. 1b). Indeed, 
NDM-1 levels in the membrane fractions after 16 h of growth were higher than those of 
IMP-1 expressed in the periplasm. As a result of this finding, we next investigated whether 
the different cellular localization of NDM-1 and IMP-1 MBLs accounts for this observation.
 Membrane-anchoring increases the in vivo stability of MBLs
In E. coli, NDM-1 is an outer-membrane lipoprotein20. Given that NDM-1 is widely found 
in both Enterobacteriaceae and non-fermenting bacteria (e.g., P. aeruginosa, Acinetobacter 
baumannii), we investigated its localization by cellular fractionation experiments both in E. 
coli and P. aeruginosa cells expressing NDM-1 (Supplementary Figs. 3 and 4). In both cases, 
the membrane fractions displayed carbapenemase activity that was inhibited by the metal 
chelator ethylenediaminetetraacetic acid (EDTA). Neither β-lactamase activity nor detectable 
NDM-1 was present in the soluble fraction. Treatment of membranes with potassium 
chloride (KCl) or sodium carbonate (Na2CO3) did not release NDM-1, whereas exposure to 
Triton X-100 produced a soluble fraction of detergent micelles that contained NDM-1. 
These detergent micelles possessed carbapenemase activity (Supplementary Fig. 3). We 
conclude that NDM-1 is membrane associated in both E. coli and P. aeruginosa and is 
anchored by hydrophobic interactions. A sucrose gradient experiment confirmed that 
NDM-1 is localized to the outer membrane in both organisms (Supplementary Figs. 4a–b). 
To further examine the cellular localization of NDM-1, we first subjected whole cells to 
limited proteolysis and observed negligible change in NDM-1 levels as a result of proteinase 
K treatment. In contrast, NDM-1 was susceptible to degradation by proteinase K in 
permeable spheroplasts (Supplementary Fig. 4c), showing that NDM-1 is localized to the 
inner leaflet of the outer membrane in both E. coli and P. aeruginosa.
This cellular localization has been attributed to the presence of a canonical lipidation amino 
acid sequence LSGC (lipobox) proximal to the NDM-1 signal peptide20. In this sequence, 
the reactive thiol moiety of the Cys residue becomes lipidated (Supplementary Fig. 4d). 
Lipoboxes are recognized and processed by the Lgt-LspA-Lnt-Lol system in bacteria, which 
also targets lipidated proteins to the membrane21. We investigated how membrane anchoring 
affects β-lactamases through the construction of mutants of NDM-1 and VIM-2 with altered 
cellular localizations (Supplementary Fig. 2a). Expression of a NDM-1 variant in which the 
lipidation site was removed by mutation of the anchoring Cys residue (C26A) resulted in 
accumulation of soluble NDM-1 in the periplasm (Fig. 2a). The same was observed for V-
NDM, a chimera of NDM-1 and the N-terminus of the soluble β-lactamase VIM-2 
(including its signal peptide) (Fig. 2a). In contrast, expression of N-VIM, a chimera of 
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VIM-2 and the N-terminal signal peptide of NDM-1, afforded a membrane-anchored variant 
of VIM-2 (Fig. 2a). We verified that N-VIM is associated to the outer membrane by cellular 
fractionation (Supplementary Fig. 4), further demonstrating the role of the lipobox in 
membrane anchoring and targeting. Using immunofluorescence microscopy we show 
different localization patterns for membrane-anchored and soluble MBLs. Membrane 
anchored MBLs appear evenly distributed along the periphery of the cell, whereas the 
soluble MBLs accumulate at the cell poles, possibly reflecting the formation of inclusion 
bodies22 (Fig. 2b). Moreover, we utilized globomycin, an inhibitor of LspA that selectively 
blocks prolipoprotein processing23, to evaluate the different processing pathways adopted by 
NDM-1 and NDM-1 C26A (Fig. 2c). Treatment of liquid cultures of E. coli expressing 
NDM-1 with globomycin led to accumulation of NDM-1 as prolipoprotein, whereas no 
effect was observed in cells expressing the soluble NDM-1 C26A variant. These results 
further establish the lipoprotein character of NDM-1 as well as the lipidation pathway.
The variants of NDM-1 and VIM-2 were active and capable of conferring resistance to E. 
coli cells against five β-lactam antibiotics (Supplementary Table 3). The soluble variants of 
NDM-1, albeit conferring similar or higher levels of resistance in lysogeny broth 
(Supplementary Table 3), were more susceptible to diminished Zn(II) levels than native 
NDM-1 (the opposite was observed for VIM-2, Supplementary Fig. 2b–c). A similar impact 
of Zn(II) deprivation on the MIC values of these variants was observed using either DPA or 
CP as chelators (Fig. 3a, Supplementary Fig. 2b and Supplementary Table 4). We studied the 
effect of Zn(II) starvation on the protein levels of these variants (Fig. 3b). After a 16-h 
exposure to Zn(II) starvation, the soluble periplasmic variants of NDM-1, C26A and V-
NDM, were almost fully degraded, whereas membrane-bound NDM-1 persisted (Fig. 3b). 
Soluble VIM-2 was almost completely degraded at 10 min, whereas its membrane-bound 
variant N-VIM was only reduced by 50% at 90 min. These data clearly show that membrane 
binding stabilizes MBLs by preventing protein degradation under conditions of Zn(II) 
starvation.
 Zn(II) protects MBLs from degradation in the periplasm
To assess the impact of Zn(II) starvation on the specific activity of the soluble (periplasmic) 
and membrane-anchored MBL variants, we measured the carbapenemase activity of whole 
living cells treated with DPA for 90 min or 16 h. We compared the carbapenemase activities 
of these DPA-treated cultures to the activities of cultures that were not treated with DPA 
(Fig. 3b and c). At 90 min, the decrease of carbapenemase activity paralleled the reduction 
of MBL expression levels in most cases (Fig. 3c). This result suggests that the detected 
MBLs in the DPA-treated samples correspond mostly to the active, Zn(II)-bound forms. 
Consequently, inactive apo-MBLs do not accumulate upon metal depletion. In contrast, N-
VIM showed a low specific activity, suggesting accumulation of the inactive apo form. This 
observation became more evident after 16 h, when the membrane-bound variants (native 
NDM-1 and N-VIM) reveal accumulation of the apo forms. These results indicate that 
membrane anchoring stabilizes MBLs, allowing for accumulation of these proteins as 
apoenzymes within the periplasmic space by protecting them from degradation (Fig. 3c).
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Subsequently, we explored the relative stabilities of the metallated and apo variants by 
exposing purified recombinant soluble NDM-1 (lacking the membrane-anchoring Cys) to 
limited proteolysis by proteinase K. Zn(II)-bound NDM-1 resisted proteolysis, whereas the 
apo form was readily degraded (Fig. 3d). This in vitro experiment demonstrates that soluble 
apo MBLs are more susceptible to proteolysis, accounting for the decrease in protein levels 
in the periplasm.
We conclude that the Zn(II) cofactor is not only essential for the hydrolytic activity of 
MBLs, but that is also essential for preventing protein degradation of soluble MBLs in the 
periplasm. For membrane-anchored variants, which can be accumulated as apo MBLs, this 
protective role of Zn(II) is not as relevant.
 Lipidated NDM-1 is secreted in outer membrane vesicles
The SBLs BRO-1 from the human pathogen Moraxella catarrhalis and PenA from 
Burkholderia pseudomallei are the only lipidated membrane-anchored β-lactamases reported 
apart from NDM-1 in Gram-negative bacteria24,25. M. catarrhalis, a common cause of 
respiratory infections, releases outer membrane vesicles (OMVs) carrying membrane-bound 
BRO-126. OMVs also harbor periplasmic β-lactamases27–29, and possibly plasmids encoding 
the genes for these enzymes, as reported for OXA-2430, the latter of which may allow for 
horizontal gene transfer. Based on these observations, we purified OMVs from E. coli strains 
expressing NDM-1. Imaging by transmission electron microscopy (TEM) confirmed that the 
vesicle preparations were homogeneous, and the vesicles exhibited diameters ranging from 
30 to 90 nm (Fig. 4a). Moreover, the OMVs presented protein profiles characteristic of outer 
membrane components, devoid of detectable cytoplasmic contaminants (Supplementary Fig. 
7).
NDM-1 was present in the OMVs, as shown by immunoblot analysis (Fig. 4b). The soluble 
periplasmic C26A variant was also present in the OMVs, albeit at markedly reduced levels. 
This observation contrasts the similar cellular expression levels of the wild-type protein and 
C26A variant (Fig. 4b). Immunoblots of OMVs isolated from cells expressing membrane-
anchored N-VIM did not reveal the presence of this variant, indicating that N-VIM was not 
localized into these vesicles (Fig. 4b). Taken together, these observations support the notion 
that membrane binding enriches the β-lactamase content in the vesicles and that secretion of 
NDM-1 into OMVs is selectively favored. NDM-1 was able to resist treatment with 
proteinase K in intact OMVs, whereas the enzyme was readily degraded in detergent-lysed 
vesicles (Fig. 4c). We conclude that NDM-1 is internally located in OMVs, thus being 
protected from extracellular proteases.
The β-lactamase activity of the OMVs was evaluated using imipenem as a substrate. The 
carbapenemase activity was five-fold larger for OMVs harboring NDM-1 compared to 
C26A-containing OMVs (Fig. 4d). β-Lactamase activity was not detected in OMVs 
produced by E. coli cells expressing the N-VIM variant. Next, we examined the β-lactamase 
activity of these OMVs under conditions of Zn(II) deprivation elicited by addition of CP. 
The carbapenemase activity of OMVs carrying NDM-1 was resistant up to 100 μg/mL of CP 
(Fig. 4e), whereas OMVs containing the soluble C26A variant were inactivated at ~5-fold 
lower levels of CP. Moreover, samples of purified soluble NDM-1 were highly susceptible to 
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CP-mediated inactivation. These experiments show that the OMV matrix exerts a protective 
role on membrane-anchored NDM-1 upon Zn(II) starvation. Full inactivation of OMV-
packaged NDM-1 at high concentrations of CP did not alter the protein levels in the vesicles 
(Fig. 4f), revealing that NDM-1 is stable as an apo protein within OMVs. We conclude that 
secretion inside OMVs ensures NDM-1 integrity in the extracellular space.
 OMVs carrying NDM-1 protect susceptible bacteria
We next tried to evaluate whether the OMVs containing NDM-1 can alter the antibiotic 
susceptibility of bacteria not producing β-lactamases. E. coli cells susceptible to β-lactam 
antibiotics were incubated with OMVs containing NDM-1. Treated cells showed an 8- to 32-
fold increase in antibiotic resistance against imipenem and cefotaxime, respectively (Fig. 
5a), compared to untreated cells. The susceptible phenotype was restored after plating the 
cells in fresh LB agar. The presence of the blaNDM-1 gene was not found in these cells by 
polymerase chain reaction (PCR), indicating that the increase in resistance was not due to a 
gene transfer event. In contrast, immunofluorescence microscopy revealed the presence of 
NDM-1 associated with OMV-treated cells (Fig. 5b) which endows them with lactamase 
activity (Supplementary Fig. 8). This result suggests that the transient increase in resistance 
results from the presence of NDM-1 protein derived from the vesicles.
In order to explore the clinical impact of these observations, we purified OMVs from 
blaNDM-harboring clinical isolates of Providencia rettgeri, Serratia marcescens and 
Enterobacter cloacae. We identified the presence of NDM-1 by Western blot in OMVs 
isolated from E. cloacae, but not in OMVs from P. rettgeri or S. marcescens (Fig. 5c). 
Moreover, we purified DNA from the lumen of these vesicles (that were pre-treated with 
DNAse I to degrade possible exogenous DNA) and analyzed the samples by PCR. The 
blaNDM gene was amplified from P. rettgeri and E. cloacae samples, as well as from the E. 
coli lab strain, but not from S. marcescens (Fig. 5d). Thus, these data suggest that the 
dissemination of NDM-1 can be fostered by OMVs released by clinical pathogens at both 
the gene and protein levels.
 Discussion
The MBL NDM-1 has become one of the most prevalent carbapenemases worldwide only a 
few years after its discovery. Here we show that membrane anchoring confers NDM-1 
several selective advantages that may have played a crucial role in its success as a resistance 
determinant. Figure 6 depicts how outer membrane-anchoring favors secretion of NDM-1 in 
OMVs and prolongs its efficacy by enhancing protein stability under Zn(II) deprivation by 
the host.
MBLs bind the Zn(II) ions in the periplasm12. Indeed, compartmentalization of metal 
binding is crucial to elicit metal binding selectivity31,32. Our Zn(II) starvation experiments 
revealed that periplasmic levels of MBLs are regulated by external Zn(II) availability. 
Periplasmic amounts of SPM-1 and NDM-1 remained stable upon Zn(II) limitation, whereas 
VIM-2 levels decreased below the detection limit. These results are in agreement with 
previous studies demonstrating that SPM-1, a MBL intrinsic to P. aeruginosa, is particularly 
optimized for conferring antibiotic resistance at low Zn(II) concentrations19. 
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Immunodetection and cell activity measurements suggest that soluble MBLs can accumulate 
in the bacterial periplasm only as metal-bound species. Thus, we attribute the decrease in 
protein levels to rapid degradation of the apo proteins formed during Zn(II) starvation. 
Protease accessibility experiments indeed show that a soluble NDM-1 variant is more 
susceptible to degradation in its apo form. Therefore, Zn(II) binding is not only essential for 
MBL activation, but also for in vivo stability. This conclusion is unexpected, since apo 
MBLs have been characterized as relatively stable variants, being amenable to structure 
determination33–35. Moreover, the stabilizing effect of the Zn(II) ions in purified proteins 
has been largely overlooked, despite thermodynamic data supporting this notion19,36–38. 
These results challenge the hypothesis suggesting that MBLs could be prevalent in the apo 
form in the absence of substrate39 and highlight the essentiality of Zn(II) binding to MBLs 
in the periplasm. To the best of our knowledge, this work is the first report of a catalytic zinc 
site essential for in vivo stabilization of a metalloprotein.
Optimization of the Zn(II)-binding affinity has been identified as an important trait gained 
along the evolutionary pathway of MBLs11,17. Membrane anchoring represents an 
alternative mechanism providing protein stability under Zn(II) starvation. This phenomenon 
was observed also for a chimeric membrane-anchored variant of the lactamase VIM-2 that is 
more stable than the native, soluble enzyme. NDM-1 accumulates as an inactive apo variant, 
suggesting that membrane-anchoring limits degradation of apo MBLs, possibly by 
restricting the accessibility to proteases and/or protein aggregation.
During infection, pathogens are exposed to large amounts of CP (with extracellular levels 
>500 μg/mL40), and other zinc-chelating proteins such as S100A12 (calgranulin C, 5% of 
neutrophil cytosolic protein)41 and S100A7 (psoriasin, abundant in the skin)42. Therefore, 
MBLs must endure Zn(II) starvation to efficiently protect bacteria from an antibiotic 
treatment. In this way, lipidation constitutes an important trait allowing NDM-1 to resist the 
action of the host innate immune system. The BRO serine-β-lactamase, despite containing a 
lipobox, is present both as a membrane-bound and a soluble form, with ratios depending on 
the bacterial host25. NDM-1 is only found in the outer membrane of E. coli and P. 
aeruginosa, suggesting that this localization provides a stronger evolutionary advantage to 
MBLs compared to SBLs.
VIM-2 is one of the most clinically successful metallo-β-lactamases, despite being sensitive 
to metal deprivation. We posit two hypotheses to account for this apparent paradox: (i) 
Bacterial strains depending on VIM-2 to survive in the presence of β-lactam antibiotics may 
only persist and cause infection at locales where the Zn(II) deprivation response is limited, 
or (ii) pathogens harboring VIM-2 may overcome metal-withholding by the host. Indeed, P. 
aeruginosa PA01 and PA14 strains are able to resist Zn(II) starvation conditions. Moreover, 
some prokaryotes use ribosomal proteins as a Zn(II) store43. Redistribution of Zn(II) within 
different stores may allow for MBL metallation in the periplasm when extracellular Zn(II) is 
restricted by the host.
We also show that NDM-1 is selectively secreted into OMVs as a consequence of outer 
membrane-anchoring. This conclusion stems from the observation that neither soluble 
NDM-1 C26A nor membrane-anchored N-VIM were efficiently secreted into OMVs. The 
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lower secretion of NDM-1 C26A into OMVs was not entirely unexpected. In E. coli, outer 
membrane proteins represent a larger proportion of the protein composition of OMVs than 
those from the periplasm44 (Supplementary Fig. 7). In contrast, the exclusion from OMVs of 
the lipid anchored OM protein N-VIM was surprising, possibly due to a cargo selection 
mechanism45,46.
Secretion of NDM-1 into OMVs illuminates another relevant evolutionary advantage: 
NDM-1-containing OMVs can protect microbes located in the immediate environment that 
would be otherwise susceptible to β-lactam antibiotics. This protection takes place by 
protein transport mediated by the vesicles. We note that these assays were performed with 
relatively high OMVs concentrations. However, OMV levels vary widely among species, 
reaching levels as high as 162 mg/L47, and pathogenic bacteria produce large amounts of 
vesicles during infection48,49. Therefore, the quantity of OMVs used here may mimic 
conditions met during the infection process.
OMVs protect packaged DNA and proteins from the extracellular environment; thus, OMVs 
have been proposed to act as vehicles for DNA and protein delivery18. Indeed, here we show 
that these vesicles shield NDM-1 from the action of extracellular proteases and from the 
Zn(II) starvation elicited by the immune system.
The worldwide dissemination of the blaNDM gene is not related to the spread of specific 
clones, plasmids, or a single genetic structure10. We propose that the transient resistance 
conferred by NDM-1-carrying OMVs may enhance the chances for horizontal gene transfer. 
This process can be particularly favored in environments like the lung, where the viscous 
nature of the airway secretions does not readily permit plasmid transfer. The finding of both 
NDM-1 protein and the blaNDM gene in OMVs secreted by clinical pathogens supports this 
hypothesis.
The conservation of the lipobox sequence in all NDM alleles (Supplementary Fig. 9) 
suggests that this evolutionary advantage is common to all known NDMs. Moreover, 
lipoboxes are present in MBLs from all three subclasses (Supplementary Fig. 10 and 
Supplementary Table 5), mostly endogenous MBLs from environmental bacteria. Thus, 
strains harboring lipidated MBLs may represent a reservoir of carbapenem resistance genes 
with enhanced potential for dissemination, which couples protein transfer via OMVs to 
horizontal gene transfer. Globomycin blocks NDM-1 processing (Fig. 2c), trapping the 
enzyme as an inner membrane-associated precursor23 and preventing NDM-1 secretion into 
vesicles, revealing a possible strategy to prevent dissemination of NDM variants.
These findings create an unprecedented opportunity to design novel antibacterial strategies 
including MBL inhibition approaches enhancing site-specific metal chelation elicited by the 
immune system together with interference of bacterial lipidation. A combination of these 
approaches may offer promise for prolonging the lifespan of the current antibiotics.
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 Online Methods
 Bacterial strains and reagents
Escherichia coli DH5α was used for construction/expression of plasmid pMBLe, 
microbiological and biochemical studies. Pseudomonas aeruginosa PAO1 was used for 
expression of the pMBLe-blaNDM-1 construct in cellular fractionation studies. P. aeruginosa 
48-1997A50, Acinetobacter junii M797851, P. aeruginosa COL-152 and plasmid pET26-
blaNDM-1, kindly provided by Dr. James Spencer (University of Bristol, UK), were used as 
the sources of blaSPM-1, blaIMP-1, blaVIM-2 and blaNDM-1 genes respectively. Clinical isolates 
producing NDM-1 used in OMV studies (Providencia rettgeri 15758, Serratia marcescens 
17468 and Enterobacter cloacae 17464) were kindly provided by Alejandra Corso (ANLIS 
“Dr. C. G. Malbran”, Argentina). Unless otherwise noted, all strains were grown aerobically 
at 37 °C in lysogeny broth (LB) medium supplemented with gentamicin 20 μg/mL when 
necessary. Chemical reagents were purchased from Sigma-Aldrich, molecular biology 
enzymes from Promega, and primers from Invitrogen.
 Plasmid constructs for expression of MBLs in E. coli and P. aeruginosa
Plasmid pMBLe was constructed with the aim of expressing the different bla genes either in 
E. coli or P. aeruginosa, retaining the native peptide leader of each lactamase. A C-terminal 
Strep-tag sequence was added to standardize protein quantitation by Western blot. MBL 
expression was induced with low concentrations of IPTG (10–50 μM) (Sigma-Aldrich, 
≥99% (TLC)) in order to avoid over-expression artifacts, intending to mimic lactamase 
levels in clinical strains (Figure 5c).
The region of plasmid pTGR1153 containing lacIQ, Ptac and transcription terminators was 
amplified with primers SacIFw (5’ GTCTAGTGAGCTCCTCTCTCAAGGGCATCG 3’) and 
NcoIRv (5’ GGAATTAAAGGTACCATGGTTAATTAATATATACTAG 3’) and subcloned 
into the SacI and NcoI sites of broad-spectrum plasmid pBBR1-MCS5 GmR 54, obtaining 
the pMBLe plasmid. Full-length bla genes (including their native peptide leaders) were 
amplified with or without addition of a C-terminal Strep-tag sequence (for comparative 
protein detection and quantification), and subcloned into NdeI and HindIII (EcoRI in the 
case of blaIMP-1) sites of pMBLe. All PCRs were carried out using Platinum ® Pfx DNA 
Polymerase (Invitrogen) with the following thermal cycle: 3 min at 95°C, 30 cycles of 15 s 
at 95°C, 30 s at 55°C and 1 min at 68ºC, and 10 min at 68ºC. Primers used for this procedure 
were IMP1NdeIFw (5’ GACATCATATGAGCAAGTTATCTGTATTC 3’), IMP1EcoRIRv (5’ 
GACGTGAATTCTTAGTTGCTTGGTTTTGATGG 3’) and IMP1StEcoRIRv (5’ 
GACGTGAATTCCTACTTTTCGAATTGTGGGTGAGACCAGTT 
GCTTGGTTTTGATGGTTTTTTAC 3’) for blaIMP-1; NDM1NdeIFw (5’ 
TATACATATGGAATTGCCCAATATTATGCACC 3’), NDM1HindIIIRv (5’ 
GACGTAAGCTTCTAGCGCAGCTTGTCGGC 3’) and NDM1StHindIIIRv (5’ 
GACGTAAGCTTCTACTTTTCGAATTGTGGGTGAGACCAGCGCAGCTTGTCGGC 3’) 
for blaNDM-1; VIM2NdeIFw (5’ 
GACATCATATGTTCAAACTTTTGAGTAAGTTATTGGTC 3’), VIM2HindIIIRv (5’ 
GACGTAAGCTTCTACTCAACGACTGAGCGATTTGTG 3’) and VIM2StHindIIIRv (5’ 
GACGTAAGCTTCTACTTTTCGAATTGTGGGTGAGACCACTCAACGACTGAGCGAT
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TTGTG 3’) for blaVIM-2; SPM1NdeIFw (5’ 
GTACGTCATATGAATTCACCTAAATCGAGAGC 3’), SPM1HindIIIRv (5’ 
GTACGTAAGCTTCTACAGTCTCATTTCGCCAAC 3’) and SPM1StHindIIIRv (5’ 
GTACGTAAGCTTCTACTTTTCGAATTGTGGGTGAGACCACAGTCTCATTTCGCCAA
C 3’) for blaSPM-1. The resulting plasmids were introduced into E. coli DH5α or P. 
aeruginosa PAO1 as previously described55, and expression of bla was induced by addition 
of 10 μM IPTG. Addition of the Strep-tag at the C-terminus did not affect MBL ability to 
confer resistance. The minimal inhibitory concentration (MIC) values of cefotaxime and 
imipenem were identical for strains expressing the wild-type or tagged variants of bla genes 
(Supplementary Table 1). All experiments were therefore performed in the Strep-tag 
containing variants.
 Construction of MBL mutants
NDM-1 C26A variant gene was generated from pMBLe-blaNDM-1 by site-directed 
mutagenesis as previously described17 using primers NDM-1-C26AFw (5’ 
CATTGATGCTGAGCGGGGCGATGCCCGGTGAAATC 3’) and NDM-1-C26ARv (5’ 
GATTTCACCGGGCATCGCCCCGCTCAGCATCAATG 3’). V-NDM (NDM-1 in which 
the first 47 amino acids are replaced by the first 42 residues of VIM-2) and N-VIM (VIM-2 
in which the first 42 amino acids are replaced by the first 47 residues of NDM-1) were 
constructed by overlap extension PCR using overlapping primers VIM2-B (5’ 
ATTCGGTGCGAGCTGGCGGAAAACCAGATCCCCGACCGGAATTTCGC 3’), NDM1-
C (5’ GATCTGGTTTTCCGCCCAGCTCGCACCG 3’), NDM1-D (5’ 
ACCATCGGCAATCTGGTAAAGCCGGACCTCGCCAAACCGTTGGTCGCC 3’), VIM2-
E (5’ GAGGTCCGGCTTTACCAGATTGCCG 3’) with external primers VIM2NdeIFw, 
NDM1NdeIFw, VIM2StHindIIIRv and NDM1StHindIIIRv. The PCR-amplified genes were 
subcloned into plasmid pMBLe as described above. All constructs were verified by DNA 
sequencing (University of Maine, USA).
 MBL detection and β-lactamase activity measurements
MBL protein levels were determined by SDS-PAGE followed by Western blot with Strep-
Tag® II monoclonal antibodies (at 1:1000 dilution from 200 μg/ml solution) 29 (Novagen) 
and immunoglobulin G-alkaline phosphatase conjugates (at 1:3000 dilution). Protein band 
intensities were quantified from PVDF membranes with ImageJ software56 and converted to 
relative protein amounts through a calibration curve constructed under the same 
experimental conditions. β-Lactamase activity was measured in a JASCO V-670 
spectrophotometer at 30ºC in 20 mM Tris pH 8.0 (for living cells) or 10 mM HEPES, 200 
mM NaCl pH 7.4 (for membranes and OMVs), in 0.1 cm cuvettes, using 400 μM imipenem 
as a substrate. Imipenem hydrolysis was monitored at 300 nm (Δε300nm = −9,000 M−1cm−1). 
In all cases, periplasmic, membrane and OMVs samples were normalized according to total 
protein concentrations, as quantified with the Pierce® BCA Protein Assay Kit (Thermo 
Scientific). Western blots with antibodies detecting periplasmic maltose binding protein 
(Rockland Immunochemicals) and cytoplasmic RNA polymerase (BioLegend) were 
performed as loading controls for periplasmic extracts and spheroplasts, respectively.
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 Cellular fractionation and analysis of NDM-1 localization
 Periplasm and spheroplasts preparations—Extraction of periplasmic proteins was 
performed as previously described12. Briefly, 2–3 mL of E. coli (or P. aeruginosa) pMBLe-
bla cultures were pelleted and cells were washed once with 20 mM Tris, 150 mM NaCl, pH 
8.0. The washed cells were resuspended in 20 mM Tris, 0.1 mM EDTA, 20% w/v sucrose, 1 
mg/mL lysozyme (from chicken egg white, Sigma-Aldrich, protein ≥90%), 0.5 mM PMSF, 
pH 8 (resuspension volume was normalized according to the formula V = 100 μL x OD600 x 
Vc, where Vc is the starting volume of culture sample), incubated with gentle agitation at 
4ºC for 30 min, and finally pelleted, with the periplasmic extract in the supernatant. The 
pellet consisting of spheroplasts was washed in 20 mM Tris, 0.1 mM EDTA, 20% w/v 
sucrose, pH 8 and resuspended in the same volume of this buffer.
 Total membranes—A 20-mL aliquot of E. coli (or P. aeruginosa) pMBLe-bla culture 
(OD600 1) induced for 2 h with 50 μM IPTG at 37ºC, was pelleted, resuspended in 10 mM 
HEPES, 200 mM NaCl, 1 mM PMSF, pH 7.4, and disrupted by sonication. Cell debris were 
removed by centrifugation at 14,000xg and 4ºC for 20 min, and membranes pelleted by 
ultracentrifugation at 150,000xg and 4ºC for 1 h. Membrane preparations were washed, 
ultracentrifuged, resuspended in the same buffer and quantified by determination of the total 
protein content using the Pierce® BCA Protein Assay Kit.
 Solubilization of membrane protein—Membrane proteins were sequentially 
extracted as previously described57. In brief, total membranes were pelleted by 
ultracentrifugation at 150,000xg and 4ºC for 1 h, resuspended in 1 M KCl, incubated for 30 
min on ice and ultracentrifuged as before, obtaining loosely associated peripheral proteins in 
supernatant. The remaining membranes were then treated with 0.1 M Na2CO3 for 30 min on 
ice to release peripheral proteins associated by strong electrostatic interactions, pelleted and 
finally treated with Triton X-100 (0.0016 and 0.23% w/v) (Sigma-Aldrich, laboratory 
grade), to extract integral or hydrophobically-associated proteins in detergent micelles.
 Separation of inner and outer membranes—Spheroplasts prepared from 250-mL 
cultures (OD600 = 1) of E. coli (or P. aeruginosa) harboring either pMBLe-blaNDM-1 or 
pMBLe-blaN-VIM were resuspended in 20 mM Tris, 1 mM PMSF, pH 8 and disrupted by 
sonication. Cell debris was removed by centrifugation at 14,000xg and 4ºC for 20 min, 
membrane vesicles pelleted by ultracentrifugation at 150,000xg and 4ºC for 1 h, and 
resuspended in 20% w/v sucrose, 20 mM Tris, pH 8. Membrane vesicles were loaded on top 
of a continuous sucrose gradient (30 to 55% w/v) in 20 mM Tris, pH 8 and ultracentrifuged 
for 16 h and 4ºC at 160,000xg in a Beckman SW 40 Ti rotor. Fractions along the gradient 
were analyzed by SDS-PAGE, Western blot and β-lactamase activity to assess the 
localization of NDM-1 or N-VIM. Inner and outer membrane vesicles were identified by 
NADH oxidase activity as previously described57, and mass spectrometry characterization of 
protein from excised gel bands (trypsin digestion followed by MS/MS, performed at Mass 
Spectrometry Laboratory for Protein Sequencing, The Cleveland Clinic Foundation, USA).
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 Analysis of NDM-1 orientation in outer membranes—Spheroplasts and whole 
cell suspensions were treated with Proteinase K (Fungal, Invitrogen, >20 U/mg) as 
previously described58, and analyzed by SDS-PAGE and immunoblotting.
 Inhibition of lipoprotein processing—Liquid cultures of E. coli pMBLe-blaNDM-1 
or pMBLe-blaNDM-1 C26A were grown at 37ºC until OD600 0.8. Globomycin (Sigma-
Aldrich, ≥98% (HPLC)) was added at a final concentration of 0, 25 or 125 μg/ml and growth 
was continued for 10 min at 28ºC. Finally, lactamase expression was induced for 1 h at 28ºC 
with 100 μM IPTG and aliquots taken for Western blot analysis.
 Minimum inhibitory concentration (MIC) determinations
Cefotaxime and imipenem MIC determinations were performed in LB medium using the 
agar macrodilution method according to CLSI guidelines59. In order to measure the effect of 
Zn(II) availability on antibiotic resistance, the growth medium was supplemented with 
varying concentrations of the metal chelator dipicolinic acid (DPA) (Merck, >98%). 
Imipenem MIC determinations in the presence of human calprotectin were performed in LB 
medium supplemented with 0, 100 or 300 μg/mL CP, using the broth microdilution 
method59. CP used in these studies was overexpressed and purified as previously 
described15. The antibacterial activity of the purified protein was confirmed against 
Escherichia coli ATCC 2592215. In all cases, bla expression was induced with 10 μM IPTG.
Relative MICs as plotted in Figures 1A, 4A and Supplementary Figure 1 were calculated as 
(MICMBL – MICcontrol)/(MICMBL + 0 μM DPA – MICcontrol + 0 μM DPA), where MICMBL and 
MICcontrol refer to values measured for E. coli DH5α pMBLe-bla or pMBLe, respectively, 
under each set of conditions, and MICMBL + 0μM DPA and MICcontrol + 0μM DPA, the 
corresponding values in media without addition of DPA.
 Effect of external Zn(II) depletion in MBL protein levels and living cells β-lactamase 
activity
E. coli pMBLe-bla cells were grown at 37ºC up to an OD600 of 0.4. MBL expression was 
induced by the addition of 50 μM IPTG, and growth was continued at 37ºC for 1 h, and then 
at 20ºC for 2 h (to slow down cellular metabolism). At this time, cultures were divided in 
two equal parts. One portion was treated with 1000 μM DPA and the other kept as an 
untreated control, and both cultures were grown at 20ºC. Aliquots of DPA-treated and 
untreated cultures were taken at different time intervals after DPA addition: 0, 10 (only for 
DPA-treated), 90 and 960 min, and periplasmic extraction performed as described to yield 
the corresponding periplasm and spheroplast fractions. Imipenem hydrolysis was measured 
in living cells from the aliquots taken at 90 and 960 min from DPA-treated and control 
samples. In brief, cells pelleted from 1 mL culture were washed and resuspended in 300 x 
OD600 μL of Chelex 100-treated (manufacturer protocol) 20 mM Tris, pH 8 buffer. β-
Lactamase activity was measured from 5 μL of cell suspension in 300 μL reaction media. 
Data were corrected by subtraction of basal hydrolysis rates observed for non-MBL-
producing control strain. Protein and activity values in DPA-treated samples were reported 
relative to the corresponding values in untreated samples.
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 Detection of cellular MBLs by immunofluorescence microscopy
E. coli cells (either lactamase-expressing or OMV treated) were washed twice with PBS, 
fixed with 0.5 ml of 3% paraformaldehyde solution in PBS for 10 min, and permeabilized 
with 0.1% Triton X-100 solution in PBS for 5 min. Subsequently, cells were incubated with 
Strep-Tag II monoclonal antibodies (1:100) and detected by incubation with anti-mouse 
Cy3-conjugated secondary antibodies (1:1000) (Invitrogen). Cells were mounted with 
SlowFadeAntifade reagent (Molecular Probes) and finally analyzed in a Nikon Eclipse E800 
fluorescence microscope (Nikon, Japan).
 Expression and purification of soluble NDM-1
The NDM-1 gene coding for residues 39 to 270 was cloned into a modified version of 
pET28 plasmid, kindly provided by Dr. Rodolfo Rasia (IBR, CONICET-UNR) in which the 
thrombin cleavage site is replaced by a TEV protease cleavage site. The protein was 
overexpressed in E. coli BL21(DE3). The bacterial culture was grown at 37 ºC in M9 
minimal medium until it reached OD600 0.6. Then, protein expression was induced by 
addition of 0.5 mM IPTG and 0.5 mM ZnSO4 to the medium. Cells were incubated 
overnight at 18 ºC, harvested by centrifugation and resuspended in lysis buffer (50 mM Tris, 
200 mM NaCl, pH 8.0). The cells were lysed by sonication and the insoluble material was 
removed by centrifugation. The protein was purified using Ni-Sepharose affinity 
chromatography, the His-tag was cleaved by treatment with His6-tagged TEV protease 
(Sigma-Aldrich, manufacturer protocol), and the tag was removed by a second 
chromatographic step with the Ni-Sepharose resin in which the protease was also retained. 
The purified protein was concentrated using a 10-kDa MW cut-off Centricon device 
(Millipore, Bedford, MA, USA). Protein concentrations were determined from the 
absorbance at 280 nm using a molar absorption coefficient (ε280) of 28,000 M−1 cm−1 
(calculated from aromatic residues using Expasy ProtParam, available at web.expasy.org/
protparam/). Apo NDM-1 was obtained by two rounds of dialysis of the purified holoprotein 
(ca. 200 μM) against 100 volumes of 10 mM HEPES, 200 mM NaCl, 20 mM EDTA, pH 7.5 
over a 12-h period under stirring. EDTA was removed from the resulting apoenzyme 
solution by three dialysis steps against 100 volumes of 10 mM HEPES, 1 M NaCl, pH 7.5, 
Chelex 100, and three dialysis steps against 100 volumes of 10 mM HEPES, 200 mM NaCl, 
pH 7.5, Chelex 100. All buffer solutions used to prepare the apoenzymes were treated by 
extensive stirring with Chelex 100 (Bio-Rad)11.
 Limited proteolysis of holo and apo recombinant NDM-1
Aliquots (200 μg) of pure recombinant holo or apo NDM-1 were treated with 2.5 μg 
proteinase K in 10 mM Tris, 5 mM CaCl2, pH 8 at 16ºC. Aliquots were taken at different 
times, the reaction was quenched with 5 mM PMSF, and samples were subjected to SDS-
PAGE and Coomassie blue staining.
 Purification of Outer Membrane Vesicles (OMVs)
OMVs were purified from early stationary phase cultures of E. coli and clinical strains. 
Briefly, 250 mL of LB medium was inoculated with 3 mL of saturated E. coli pMBLe-bla 
culture, grown at 37ºC up to OD600 of 0.4, induced with 20 μM IPTG, and growth continued 
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overnight with agitation. In the case of clinical strains, 250 mL of LB broth was inoculated 
with 3 mL of saturated culture and grown for 5 h at 37ºC. The cells were harvested and the 
supernatant filtered through a 0.45-μm membrane (Millipore). Ammonium sulfate was 
added to the filtrate at a concentration of 55% w/v, followed by incubation with stirring at 
4ºC for 3 h (E. coli) or overnight (clinical strains). Precipitated material was separated by 
centrifugation at 12,800xg for 10 min, resuspended in 10 mM HEPES, 200 mM NaCl, pH 
7.4 and dialyzed overnight against >100 volumes of the same buffer. Next, the samples were 
filtered through a 0.45-μm membrane, layered over an equal volume of 50 % w/v sucrose 
solution and ultracentrifuged at 150,000xg for 1 h and 4ºC. Pellets, containing OMVs, were 
washed once with 10 mM HEPES, 200 mM NaCl, pH 7.4 and further purified by sucrose 
isopycnic density gradient ultracentrifugation in equal buffer. Fractions containing OMVs 
(those possessing an SDS-PAGE pattern corresponding to the main outer membrane 
proteins) were pooled, washed with 10 mM HEPES, 200 mM NaCl, pH 7.4 and stored at –
80ºC until use. 10 microliters of a 300 μg/ml OMV preparation was plated on LB agar and 
determined to be sterile. OMV yields were of ~200 μg protein/250 mL culture. Quality of 
vesicle preps was assessed by negative staining transmission electron microscopy, as 
described elsewhere30. Briefly, vesicles were fixed in 4% glutaraldehyde in 10 mM HEPES, 
200 mM NaCl, pH 7.4 for 30 min at room temperature, stained with 2% uranyl acetate and 
visualized in a Zeiss EM 109T Transmission Electron Microscope. Finally, the absence of 
cellular contaminants due to cell lysis during culture growth or cell manipulation was 
verified by immunodetection of cytoplasmic GroEL in OMV preps. Additionally, OMVs and 
samples from different fractions of E. coli pMBLe-blaNDM-1 (cytoplasmic, periplasmic, 
inner-membrane and outer-membrane58,60) were analyzed by SDS-PAGE and their protein 
patterns compared. GroEL antibodies were kindly provided by Dr. Alejandro Viale (IBR).
 Localization of NDM-1 in OMVs
A 16-μg aliquot of intact or previously lysed OMVs were incubated with 100 μg proteinase 
K in 10 mM Tris, 5 mM CaCl2, pH 8 at 25ºC. Aliquots were taken at 10 and 60 min, 
protease was inactivated with 5 mM PMSF, and samples analyzed by SDS-PAGE and 
immunoblotting. OMV lysis was performed by treatment with 0.125% v/v Triton X-100 for 
30 min at 37°C, as previously described30.
 Evaluation of β-lactam resistance transfer by OMVs
β-lactam sensitive E. coli cells, carrying empty pMBLe plasmid, were grown at 37ºC in 8 
mL LB medium to an OD600 of 0.5, centrifuged at 6,000xg for 10 min and resuspended in 
240 μL of 10 mM HEPES, 200 mM NaCl, pH 7.4. 1 μL of this suspension was mixed with 8 
μg of NDM-1, NDM-1 C26A or non-MBL-producing OMVs, and incubated statically for 1 
h at 37ºC. The mixture was diluted 1/10 in 10 mM HEPES, 200 mM NaCl, pH 7.4 and 3 μL 
drops used for MIC determinations in LB-agar plates.
 Effect of calprotectin on OMV lactamase activity
OMVs harboring NDM-1 or NDM-1 C26A (0.8 μg) were incubated for 2 min at 30ºC in 10 
mM HEPES, 200 mM NaCl, pH 7.5 buffer with different amounts of calprotectin (0–300 μg/
mL). After incubation, 500 μM imipenem was added and the remnant β-lactamase activity 
was determined spectrophotometrically. The same experiment was also performed with 
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purified soluble recombinant NDM-1, adjusting the protein concentration to match the 
activity of the NDM-1 OMV sample in absence of calprotectin.
 Purification of DNA from vesicles
OMV samples (10 μg) were treated with 50 μg/mL DNase I (Sigma) for 1 h at 37ºC to 
hydrolyze surface-associated DNA and free DNA in suspension. Reactions were stopped by 
incubation for 10 min at 80ºC. DNase-treated vesicles were then lysed with 0.125% Triton 
X-100 solution for 30 min at 37°C, and DNA was purified by the use of Wizard® SV Gel 
and PCR Clean-Up System (Promega). The DNA was quantified by using a Nanodrop 2000 
(Thermo Scientific). Average yields were as follows: E. coli pMBLe-blaNDM-1 13 ± 4 ng/μg 
OMV, P. rettgeri 59 ± 30 ng/μg OMV, S. marcescens 28 ± 9 ng/μg OMV, E. cloacae 51 ± 14 
ng/μg OMV.
PCR amplification of blaNDM-1 was performed using 50 ng DNA as template, with primers 
NDM1NdeIFw and NDM1HindIIIRv, as already described. Amplifications were carried out 
from two independent preparations of vesicle DNA. Negative controls indicated that DNA 
contamination did not occur.
 Bioinformatic search of lipobox-containing lactamases
Homologues to subclass B1, B2 and B3 MBLs were extracted from the NCBI non-
redundant protein database, and depurated for further analysis. In the case of B1 and B2 
MBLs, sequences not containing the typical motifs HXHXD and GGC, for B1, or NXHXD 
and GNC, for B2, were discarded. In a similar way, B3 homologues not possessing the 
HXHXDH motif and sequence identity >25% to GOB-1 were excluded. Afterwards, 
proteins containing the lipobox consensus sequence [LVI][ASTVI][GAS][C] within their 
first 50 residues were selected and analyzed with DOLOP (http://www.mrc-lmb.cam.ac.uk/
genomes/dolop/) and LipoP (http://www.cbs.dtu.dk/services/LipoP/) lipoprotein predictors. 
Positive sequences were aligned with the structure-assisted multiple sequence alignment tool 
Expresso (http://www.tcoffee.org/) and phylogenetic trees were constructed (LG substitution 
model and 100 bootstraps) using the maximum likelihood algorithm PhyML, available at 
http://www.phylogeny.fr. Unrooted trees were drawn with DrawTree from the Phylip 
package (available at http://www.evolution.genetics.washington.edu/phylip.html).
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Zn(II) deprivation reduces bacterial antibiotic resistance and causes degradation of 
MBLs in the Escherichia coli periplasm
(a) Relative MIC values of cefotaxime for E. coli cells expressing VIM-2, NDM-1, IMP-1 or 
SPM-1 in growth medium supplemented with different concentrations of the metal chelator 
DPA. MIC ratio values were calculated as described in the Methods section. Data 
correspond to three independent experiments, with standard errors ≤16% of each data point. 
(b) Western blot analysis of MBL levels in cells grown under conditions equivalent to those 
used for MIC assays, with (+) and without (–) addition of 350 μM DPA or 250 μg/mL CP to 
the growth medium. Original Western Blots are displayed in Supplementary Figure 11 (c) 
Relative MBL levels in the bacterial periplasm as a function of time after addition of 1000 
μM DPA. Protein levels were quantified from Western blots (Supplementary Fig. 1b), 
normalized to control samples not treated with DPA, and plotted as the % of initial protein 
content remaining after treatment with DPA. Data correspond to three independent 
experiments and are shown as mean ± s.e.m.
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Figure 2. The cellular localization of MBLs is determined by their N-terminal region
(a) Western-blot analysis of NDM-1, NDM-1 C26A, V-NDM, VIM-2 and N-VIM variants 
in spheroplasts (S) and periplasmic fractions (P) obtained from Escherichia coli. (b) 
Immunofluorescence microscopy of soluble and membrane-anchored variants of NDM-1 
and VIM-2. E. coli cells expressing the MBLs (fused to a C-terminal Strep tag sequence) 
were fixed, probed with anti-Strep tag and Cy3-conjugated anti-IgG antibodies, and 
visualized by fluorescence microscopy. Arrows indicate putative inclusion bodies at cell 
poles. The negative control with E. coli cells not expressing any MBL gave no detectable 
fluorescence signal. Scale bars correspond to 3 μm. (c) NDM-1 and NDM-1 C26A levels by 
Western blot in whole cells expressing MBLs after exposure to 0, 25 or 125 μg/mL 
globomycin. Original Western Blots for panels (a) and (c) are displayed in Supplementary 
Figure 11.
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Figure 3. Membrane-anchoring protects NDM-1 from degradation upon Zn(II) deprivation
(a) Relative MICs of cefotaxime for E. coli cells expressing wild type or mutant variants of 
NDM-1 in growth medium supplemented with different concentrations of the metal chelator 
DPA. Data correspond to three independent experiments, with standard errors ≤16% of each 
data point. (b) MBL levels in periplasmic (solid lines) or membrane (dashed lines) fractions 
as a function of time after addition of 1000 μM DPA, relative to levels in untreated control 
samples grown in the same conditions. Data correspond to three independent experiments 
and are shown as mean ± s.e.m. (c) Comparison between whole cell imipenem hydrolysis 
rates and periplasmic MBL levels after 90-minute incubation with 1000 μM DPA. Values are 
relative to untreated control samples grown in the same conditions, and protein levels 
correspond to those of Fig. 3b. The same data was determined for membrane bound variants 
after 960 minutes. Data correspond to three independent experiments are shown as mean ± 
s.e.m. Equal amounts of total protein were loaded on gels for each sample. (d) Limited 
proteolysis of purified recombinant NDM-1 (a soluble variant lacking the lipobox sequence), 
in its Zn(II)-bound or apo form. Aliquots were taken at various time intervals after addition 
of 2.5 μg proteinase K to solutions of 200 μg protein, and analyzed by SDS-PAGE. Original 
gel is displayed in Supplementary Figure 11.
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Figure 4. Membrane-anchoring favors secretion of NDM-1 into outer membrane vesicles 
(OMVs)
(a) Negative stain TEM of OMVs from E. coli cells expressing NDM- 1. (b) MBL levels in 
whole cells expressing NDM-1, NDM-1 C26A or N-VIM and OMVs purified from their cell 
culture supernatants. Gel lanes were loaded with equal amounts of total protein. (c) Western 
blot of intact (–) and lysed OMVs (+, treated with 0.1 % Triton X-100) upon treatment with 
100 μg/mL proteinase K. (d) Imipenem hydrolysis by OMVs purified from E. coli cells 
expressing NDM-1, NDM-1 C26A and N-VIM. Data correspond to three independent 
experiments and are shown as mean ± s.e.m. (e) Effect of calprotectin on the imipenemase 
activity of OMVs (0.8 μg) containing NDM-1 or NDM-1 C26A, compared to recombinant 
NDM-1 (6 nM). Data correspond to mean values from two independent experiments. (f) 
Effect of calprotectin on NDM-1 levels in OMVs. NDM-1 OMVs were incubated for 20 
minutes at 37ºC in 10 mM HEPES, 200 mM NaCl at pH 7.4 with or without addition of 
calprotectin 500 μg/mL. Top, relative imipenem hydrolysis rates of OMVs; bottom, Western 
blot showing NDM-1 levels in OMVs. Data correspond to mean values from two 
independent experiments. Original Western Blots for panels (b), (c) and (f) are displayed in 
Supplementary Figure 11.
González et al. Page 23
Nat Chem Biol. Author manuscript; available in PMC 2016 November 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. NDM-1-carrying OMVs provide carbapenem resistance to susceptible bacteria
(a) Relative MIC values (shown as number of dilutions over control strain) of β-lactam-
sensitive cells after treatment with OMVs purified from cells expressing native NDM-1, 
NDM-1 C26A or control (pMBLe). Data correspond to mean values from two independent 
experiments. (b) Immunofluorescence microscopy analysis of β-lactam-sensitive E. coli cells 
(not expressing MBLs) after 1 h incubation with OMVs purified from cells expressing 
NDM-1. Cells were washed from OMVs, fixed and probed with anti-Strep tag and Cy3-
conjugated anti-IgG antibodies for fluorescence microscopy. Above, Cy3 visualization; 
below, cells detected by autofluorescence. The negative control with E. coli cells not 
expressing any MBL gave no detectable fluorescence signal. Scale bars correspond to 3 μm 
(c) Immunodetection of NDM-1 in whole cells and OMVs from clinical strains P. rettgeri, S. 
marcescens and E. cloacae compared to lab E. coli expressing NDM-1 and NDM-1 C26A. 
The presence of cytoplasmic contaminants in vesicle preps was assessed by Western blot of 
GroEL. (d) PCR detection of NDM-1 gene in whole cells and OMVs. Original Western 
Blots and gels for panels (c), and (d) are displayed in Supplementary Figure 11.
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Figure 6. Membrane-anchoring assures long-term survival of NDM-1
Membrane- anchoring increases protein stability under Zn(II) deprivation, as elicited by host 
calprotectin during infection, and favors protein (together with blaNDM-1) secretion into 
OMVs, providing transient resistance to nearby populations of bacteria.
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